Identification of angiopoietin-2/Tie signaling molecules as a predictive biomarkers for ICI resistance in melanoma by Adam Smartt | Apr 15, 2022 | Other
Innovative Approaches for GNAQ/11 Mutant Characterization and Therapeutic Targeting by MRF Programs Team | Oct 31, 2018 | Other
A Study to Estimate the Anti-Tumor Activity and Identify Potential Predictors of Response in Patients with Advanced Mucosal or Acral Lentiginous Melanoma Receiving Standard Nivolumab in Combination with Ipilimumab followed by Nivolumab Monotherapy by Adam Smartt | Jan 25, 2018 | Other
Recent Comments